NCT00219297 2021-02-21
Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
Novartis
Phase 2 Completed
Clinical Trials
20 trialsNCT00262990 2020-12-17
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
Novartis
Phase 3 Completed
NCT00411528 2020-12-17
Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer
Novartis
Phase 2 Completed
NCT00420524 2020-12-09
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
Novartis
Phase 1 Completed
NCT00426582 2020-12-09
Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors
Novartis
Phase 1 Completed
NCT00420615 2020-12-08
Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies
Novartis
Phase 1 Completed
NCT00426140 2020-12-08
Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.
Novartis
Phase 1 Completed
NCT00969046 2020-12-08
Dose-Escalation Study in Advanced Colon Cancer Patients
Novartis
Phase 1 Completed
NCT00050349 2017-03-01
EPO906 in Carcinoid and Other Neuroendocrine Tumors
Novartis
Phase 2 Completed
NCT00035113 2017-02-09
EPO906 Therapy in Patients With Prostate Cancer
Novartis
Phase 2 Completed
NCT00035126 2017-02-08
EPO906 Therapy in Patients With Advanced Breast Cancer
Novartis
Phase 2 Completed
NCT00273312 2017-02-07
Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma
Novartis
Phase 2 Completed
NCT00171834 2014-02-05
Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer
Novartis
Phase 1/2 Completed
NCT00035087 2013-12-04
EPO906 Therapy in Patients With Advanced Colorectal Cancer
Novartis
Phase 2 Completed
NCT00035165 2012-04-25
EPO906 Therapy in Patients With Advanced Melanoma
Novartis
Phase 2 Completed
NCT00035243 2012-04-17
EPO906 Therapy in Patients With Advanced Kidney Cancer
Novartis
Phase 2 Completed
NCT00035100 2012-04-16
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Novartis
Phase 2 Completed
NCT00421044 2012-01-11
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
Novartis
Phase 1 Completed
NCT00412789 2010-05-31
Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan
Novartis
Phase 1 Completed
NCT00448396 2009-11-19
Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies
Novartis
Phase 1 Completed